Anti-IgE treatment: an update.
Babu
K S
KS
Medical Specialties, Mail Point 810, Southampton General Hospital, Southampton SO16 6YD, UK.
Arshad
S H
SH
Holgate
S T
ST
D000293:Adolescent; D000328:Adult; D018926:Anti-Allergic Agents / Q000627:therapeutic use*; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001249:Asthma / Q000188:drug therapy; D002648:Child; D017326:Clinical Trials, Phase III as Topic; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood / Q000276:immunology*; D000069444:Omalizumab; D012130:Respiratory Hypersensitivity / Q000188:drug therapy* / Q000276:immunology; D012221:Rhinitis, Allergic, Perennial / Q000188:drug therapy; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy
D018926:Anti-Allergic Agents; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab; D007073:Immunoglobulin E